MEASLES HEALTH ALERT/ADVISORY. Date: February 5, Dear Colleague:

Similar documents
HEALTH ADVISORY: MEASLES EXPOSURES IN NEW YORK STATE

Measles Update. March 16, 2015 Lisa Miller, MD, MSPH Communicable Disease Branch Chief Lynn Trefren MSN, RN Immunization Branch Chief

Spots and Pox: Contact Tracing and Follow Up for Measles and Chickenpox

Spots and Pox: Contact Tracing and Follow Up for Measles and Chickenpox

Measles 2015: What We Need to Know

Measles and Measles Vaccine

Immunization-Preventable Outbreaks, Matt Zahn, MD Medical Director Epidemiology and Assessment Orange County Health Care Agency May 5, 2014

Measles, Mumps and Rubella. Ch 10, 11 & 12

Measles rev Jan 2018

Wisconsin physicians, other clinicians, infection control professionals, local health department directors in Wisconsin

Measles Redux FEBRUARY 26, Karen Holbrook, MD MPH Deputy Health Officer

MEASLES. Tracey Johnson Infection Control Specialist Nurse

New Jersey Department of Health Vaccine Preventable Disease Program Measles Clinical FAQs. Date: June 14, 2013

Case Definition Reporting Requirements Remainder of the Guideline (i.e., Etiology to References sections inclusive)

BCCDC Measles, Mumps and Rubella Enhanced Surveillance Case Report Form

Measles: United States, January 1 through June 10, 2011

DISCLOSURES. I have no actual or potential conflicts of interest in this presentation.

9/11/2018. Measles. Measles, Mumps, and Rubella. Measles Complications. Paramyxovirus Nasopharynx is primary site of infection

This SOP applies to all staff employed by NHS Greater Glasgow & Clyde and locum staff on fixed term contracts and volunteer staff.

The pages that follow contain information critical to protecting the health of your patients and the citizens of Colorado.

Dr Tara Anderson ACIPC 24 th November 2015

MEASLES SURVEILLANCE PROTOCOL FOR ONTARIO HOSPITALS

5/13/2015 TODAY S TOPICS SURVEILLANCE, REPORTING AND CONTROL OF VACCINE PREVENTABLE DISEASES 2015

The Virtual Immunization Communication (VIC) Network is a project of the National Public Health Information Coalition (NPHIC) and the California

MICHAEL PARK A RUDOLF STEINER SCHOOL

County of Santa Cruz. General Questions About Measles HEALTH SERVICES AGENCY. Public Health Division. What is measles?

MEASLES, MUMPS, RUBELLA (MMR)

Measles, Mumps, and Pertussis. UALBH Annual Symposium September 8, 2017 Gary Edwards, Executive Director

New Jersey Dept. of Health and Senior Services Vaccine Preventable Disease Program Measles Public FAQs. Date: June 8, 2011

Objectives 3/3/2017. Disease Reporting in Georgia: The School Nurse s Role. Georgia Department of Public Health

Measles. Paul R. Cieslak, MD Public Health Division February 7, 2019

EXANTHEMATOUS ILLNESS. IAP UG Teaching slides

Introduction to Measles a Priority Vaccine Preventable Disease (VPD) in Africa

Viral Vaccines I 5/17/04 LECTURE OUTLINE I. CASE HISTORY

Healthy Kansans living in safe and sustainable environments.

Quote. These are my principles. If you don t like them I have others. Groucho Marx

Measles Makes a Comeback Epidemiology and Laboratory Testing

April 26, Typical symptoms include: cough - 85% nasal congestion - 81% nasal discharge - 70% sore throat - 52% fever - 44% headache - 30%

Chapter 6: Measles. I. Disease description. II. Background

Guidelines for Control of Measles in Ireland

It IS a Small World After All: The Public Health Impact and Immunologic Assessment of a Disneyland Measles Case in El Paso County, Colorado

Varicella Epidemiology and Testing. Lexie Barber Varicella Epidemiologist November 2, 2018

Rubella rev Jan 2018

A rash case Infection control management of measles

Vaccine Preventable Disease (VPD)

NYS Trends in Vaccine Preventable Disease Control

Measles Disease: Q & A

Public Health measles response

Measles in Ireland, 2005

The Northern Kentucky Health Department advises that you take the following actions:

10/29/2015. Communicable Disease Outbreaks: Methods of Control. Objectives. Review of the Basics

NJDOH Communicable Disease Forum

Guidance for Influenza in Long-Term Care Facilities

IMMUNIZATION PROTOCOLS FOR PHARMACISTS. VARICELLA Live Virus Vaccine

The Resurgence of Affliction Measles: The Current Situation

Vaccine Preventable Diseases. Overview MEASLES 4/8/2015. Amy Schwartz, MPH Immunization Surveillance Coordinator North Dakota Department of Health

for Pharmacists and Pharmacy Technicians

Haemophilus influenzae, Invasive Disease rev Jan 2018

Diseases of Absence. Disclosures

Measles Elimination Dr. Suzanne Cotter 4 th National Immunisation Conference 2007

Influenza-Associated Pediatric Mortality rev Jan 2018

MEASLES (campak, rubeola, gabak, kerumut) Infectious and Tropical Pediatric Division Department of Child Health, Medical Faculty, University of Sumate

Measles (Rubeola) Biology of measles virus. April 20, 2017 Department of Public Health Sciences

HEALTH ADVISORY Mumps outbreaks in Colorado Feb. 8, Key points. Health care providers: Please distribute widely in your office

Update on Mumps and Current Status of Outbreak in NW Arkansas

Module on best practices for measles surveillance

Measles & Mumps: implications for college health

Are You Ready For A Measles Outbreak? Lessons from Minnesota 2017 Outbreak

Measles Measles Measles Virus Pathogenesis

Elizabeth Tenney Infectious Disease Epidemiology Homework 2 Texarkana Epidemic Measles in a Divided City Question 1a: Any outbreak of measles is cause

Emerging Pathogens and Outbreaks

Management of Vaccine Preventable Diseases in 2016

SURVEILLANCE, REPORTING AND CONTROL OF VACCINE-PREVENTABLE DISEASES: WORKING TOGETHER TO CONTROL THE SPREAD

Measles Measles Measles Virus Pathogenesis 173

A summary of guidance related to viral rash in pregnancy

Mumps DISEASE REPORTABLE WITHIN 24 HOURS OF DIAGNOSIS

Measles. Chapter 12 Measles. Measles. Measles vaccine introduced in 1985/ MMR introduced in 1988 NOTIFIABLE

VACCINE PREVENTABLE DISEASE EPIDEMIOLOGY

Vaccine Preventable Diseases and healthcare workers

Union Theological Seminary New Student Immunization Requirement

Yolo County Health Department Communicable Disease Update

Measles: Back again. Measles continues to rear its head ABSTRACT KEY POINTS

DESCRIPTION OF MUMPS

ICM VI-09 DEFINITION REFERENCES

Prevent Measles Example of Fact sheet for health workers in Fiji

The pages that follow contain information critical to protecting the health of your patients and the citizens of Colorado.

Hepatitis C January 26, 2018

The Ministry of Health recommends measles vaccines for all child care providers, children and parents to ensure they are protected against measles.

Dr. Cristina Gutierrez, Laboratory Director, CARPHA SARI/ARI SURVEILLANCE IN CARPHA MEMBER STATES

Appendix B: Provincial Case Definitions for Reportable Diseases

Influenza and the Flu Shot Facts for Health Care Workers

Immunization and Vaccines

Healthcare Personnel Immunization Recommendations

Elizabeth Hinson ID Homework #2

Bacteria: Scarlet fever, Staph infection (sepsis, 4S,toxic shock syndrome), Meningococcemia, typhoid Mycoplasma Rickettsial infection

Epidemiology Update Hepatitis A

Measles Surveillance in the United States: An Overview

Mumps. Ellen Dorshow-Gordon, MPH Jackson County Health Department March Follow Us on Social Media:

Healthcare Professionals

Surveillance, Reporting and Control of Influenza and Pertussis. Steve Fleming, EdM Hillary Johnson, MHS Epidemiologists Immunization Program, MDPH

Transcription:

MEASLES HEALTH ALERT/ADVISORY Date: February 5, 2019 Dear Colleague: Details of situation: Five measles cases, four between the ages of 12 to 21 months, have been reported in three different counties within the of State Health Services Region 6/5 South (Southeast Texas). Vaccination remains the most effective method for preventing measles. Two of the cases had their immunizations administered only 1-3 weeks prior to developing symptoms. Genotyping has revealed the cases were B3 strain, the most common strain currently circulating in Mexico and the second most common strain seen in Canada and the United States. The current vaccine, which contains strain A, is effective against B3 and has demonstrated a high protection rate (95-98% seroconversion with the first dose and 99% with the second dose). One of the cases was an adult linked to one of the infant cases. Measles is highly contagious and early identification remains a critical public health measure to reduce the spread of the disease. We are working with local health departments regarding the reported cases. Please consider measles as a part of your differential diagnosis if you see patients with the clinical signs and symptoms described below. Clinical information: Measles (rubeola) is a highly contagious febrile rash illness caused by a paramyxovirus transmitted via the respiratory route. The incubation period averages 10-12 days from exposure to prodrome and 14 days from exposure to rash onset (range 7-18 days). The prodrome generally lasts 2-4 days and is characterized by fever, increasing in stepwise fashion and often peaking at 103-105 F. Fever is followed by the onset of cough, coryza, and/or conjunctivitis. Koplik spots, while not always present, are considered to be pathognomonic for measles and appear as punctate blue-white spots on the bright red background of the buccal mucosa, occurring 1-2 days before rash to 1-2 days afterwards. The measles rash is a maculopapular eruption that begins at the hairline and gradually proceeds to face and upper neck and from there downward and outward. The maculopapular lesions are generally discrete but may become confluent. Other symptoms of measles include anorexia, diarrhea (especially in infants), and

generalized lymphadenopathy. Complications can include otitis media, pneumonia, encephalitis, seizures and death. While it is rare that vaccinated individuals develop measles, it can happen. Vaccinated individuals may have an atypical clinical presentation typically shorter rash duration or atypical rash presentation, and possible lack of fever, cough, coryza or conjunctivitis. Disease Reporting Requirements/Statute: Several Texas laws (Health & Safety Code, Chapters 81, 84, and 87) require specific information regarding notifiable conditions be provided to the health department. Health care providers, hospitals, laboratories, schools, childcare facilities and others are required to report patients who are suspected of having measles (Chapter 97, Title 25, Texas Administrative Code). In Texas, suspicion of measles is required to be reported immediately. Do not wait for laboratory confirmation to report measles. Measles reports should be made to the local health department or 800-705-8868. Infection Control: Patients are contagious from 4 days before onset of rash to 4 days after appearance of rash (day of rash onset is day 0). If a patient presents with these symptoms, isolate the patient with airborne isolation precautions, if possible. All healthcare facilities should ensure that they have updated documentation of measles immunity status for all staff not just healthcare providers. Documentation of immunity includes written record of receipt of two MMRs, positive serological titers, or birth prior to 1957 (although healthcare facilities should consider vaccinating unvaccinated personnel born before 1957 who do not have laboratory evidence of measles immunity). During an outbreak of measles, unvaccinated healthcare workers regardless of birth year who lack laboratory evidence of immunity should receive 2 doses of MMR vaccine. Exclude healthcare personnel without evidence of immunity from duty from day 5-21 after last exposure, regardless of post-exposure prophylaxis. People suspected of having measles should be advised to stay home from work, school, daycare, and any public outings (e.g., church, grocery store) until four days after rash onset have passed. People that have been exposed to measles and are not immune and did not receive PEP should be advised to stay home from day 5-21 after exposure.

Lab Confirmation Tests: Testing for measles should be done in patients meeting clinical case definition: (1) a generalized rash lasting >3 days, and (2) fever >101F (38.3C), and (3) cough, coryza or conjunctivitis. A blood specimen for serology and throat swab for viral culture or PCR should be collected at the first contact with a suspected measles case. Currently PCR is only available through public health laboratories. Work with the local health department to coordinate PCR testing. For serological testing performed, please provide both IgM and IgG test results to your local health department. Testing should also be considered in persons who have been exposed or travelled to an area where measles is endemic and who have a rash-fever illness. Postexposure Prophylaxis (PEP) Recommendations: MMR vaccine is recommended for the following potentially exposed groups: Exposed persons (6 months and older and not otherwise contraindicated) without evidence of immunity to measles administer MMR within 3 days of exposure. If a child <12 months old is vaccinated for a potential exposure, he should be revaccinated with 2 additional doses of MMR according to schedule. Immune globulin IGIM 0.5 ml/kg of body weight (maximum dose = 15 ml) is recommended for the following potentially exposed groups: Infants 0-6months within 6 days of exposure Any susceptible, immunocompetent, exposed individual (except pregnant women), if the window for MMR PEP has passed and it is still within 6 days of exposure Priority for IG should be given to infants, household contacts, anyone at risk for complications, and anyone with prolonged, close contact. IGIV 400 mg/kg is recommended for the following potentially exposed groups within 6 days of exposure: Severely immunocompromised persons Pregnant women without evidence of measles immunity Any nonimmune person exposed to measles who received IG should subsequently receive MMR vaccine, which should be administered no earlier than 6 months after IGIM administration or 8 months after IGIV administration provided the person is then aged 12 months and the vaccine is not otherwise contraindicated.

Routine Vaccination: All patients should be kept current with measles vaccination. Check the vaccination history of all patients and offer vaccine to anyone that is not up to date with the vaccine schedule. Maintaining high two-dose MMR vaccination coverage in communities remains the most effective way to prevent outbreaks. If you have further questions or need to report measles case(s), please contact your local health department: Brazoria County Health Telephone: (979) 864-2168 Fax: (979) 864-3694 After hours: (800) 511-1632 https://brazoriacountytx.gov/hom e City of Beaumont Health Telephone: (409) 832-4000 Fax: (409) 835-2545 After hours: 409-839-4208 https://beaumonttexas.gov/depart ments/health-services/ City of Port Arthur Health Telephone: (409) 983-8848 Fax: (409) 982-5616 After hours: (409) 981-9901 https://www.portarthurtx.gov/213 /Health- Chambers County Health Telephone: (409) 267-2731 Fax: (409) 267-4276 After hours: (409) 267-9862 https://www.co.chambers.tx.us/page/healt h.department Fort Bend County Health & Human Services Telephone: (281) 342-6414 Fax: (281) 342-7371 After hours: (281) 434-6494 http://www.fbchealth.org/ Galveston County Health District Telephone: (409) 938-2322 Fax: (409) 938-2399 After hours: (888) 241-0442 www.gchd.org Hardin County Health Telephone: (409) 246-5188 Fax: (409) 246-4373 After hours: 409-659-7759 http://www.hardincountytexas.us/ PublicHealth/publichealth.htm Harris County Public Health Telephone: (713) 439-6000 Fax: (713) 439-6306 After hours: (713) 755-5000 https://publichealth.harriscountytx.gov/

Houston Health Telephone: (832) 393-5080 Fax: (832) 393-5232 After hours: (832) 393-5080 http://www.houstontx.gov/health/ Montgomery County Public Health District Telephone: (936) 523-5026 Fax: (936) 539-9272 After hours: (888) 825-9754 https://mcphd-tx.org/ Orange County Health Telephone: (409) 246-5188 Fax: (409) 246-4373 After hours: 409-659-7759 http://www.hardincountytexas.us/ PublicHealth/publichealth.htm If you are not in one of the above jurisdictions, contact our office: of State Health Services, Region 6/5 South Telephone: (713) 767-3000 Fax: (713) 767-3006 After hours: 800-270-3128 https://dshs.texas.gov/region6-5/default.shtm Best Regards, Carlos Plasencia, MD, MSPH Regional Medical Director Public Health Region 6/5S Texas of State Health Services 5425 Polk Street, MC 1906 Houston, TX 77023